+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05663359

Comparing Two Laser Wavelengths, 1940 nm vs 1470 nm, for Treating Varicose Veins in the Legs Using Endovenous Laser Ablation

Led by Clinique Pasteur · Updated on 2026-03-06

280

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the effectiveness and safety of two different wavelengths of endovenous laser ablation EVLA treatment for varicose veins in the lower limbs. The study aims to find out if increasing the laser wavelength from 1470 nm to 1940 nm affects treatment success and whether it reduces complications or pain. Participants are patients with varicose veins who are candidates for EVLA treatment. The trial randomizes participants to receive EVLA with either a 1940 nm laser or a 1470 nm laser. After the laser treatment, patients are followed for five years to monitor clinical outcomes, treatment complications, and quality of life. The study compares these two strategies to evaluate if the higher wavelength maintains efficacy and reduces side effects. During the study, participants will undergo clinical assessments and report pain levels at multiple time points, including day 0, day 8, month 6, and annually up to five years. Researchers will collect data on anatomical success, venous severity, symptoms, adverse events, and quality of life through evaluations and questionnaires. Long-term follow-up ensures comprehensive monitoring of treatment results and safety.

CONDITIONS

Brief Title

Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm)

Research Team

N

Nicolas NEAUME, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here